These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16153449)

  • 21. Combined peri-ischemic administration of Bβ15-42 in treating ischemia reperfusion injury of the mouse kidney.
    Urbschat A; Rupprecht K; Zacharowski K; Obermüller N; Scheller B; Holfeld J; Tepeköylü C; Hofmann R; Paulus P
    Microvasc Res; 2015 Sep; 101():48-54. PubMed ID: 26116861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
    Tao X; Chen X; Hou Z; Hao S; Liu B
    World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion.
    Hamby AM; Suh SW; Kauppinen TM; Swanson RA
    Stroke; 2007 Feb; 38(2 Suppl):632-6. PubMed ID: 17261705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
    Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
    Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
    Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin.
    Mishra J; Mori K; Ma Q; Kelly C; Yang J; Mitsnefes M; Barasch J; Devarajan P
    J Am Soc Nephrol; 2004 Dec; 15(12):3073-82. PubMed ID: 15579510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia.
    Schmidt-Ott KM; Mori K; Kalandadze A; Li JY; Paragas N; Nicholas T; Devarajan P; Barasch J
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):442-9. PubMed ID: 16775460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
    Jiao Y; Li G
    Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
    Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
    Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?
    Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O
    Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of cell cycle progression by poly(ADP-ribose) polymerase inhibitor PJ34 in neural stem/progenitor cells.
    Kurokawa S; Okuda A; Nishizawa Y; Furukawa K; Sumihiro A; Nakaji Y; Tanaka S; Takehashi M
    Biochem Biophys Res Commun; 2019 Feb; 510(1):59-64. PubMed ID: 30665718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model.
    Hamahata A; Enkhbaatar P; Lange M; Yamaki T; Sakurai H; Shimoda K; Nakazawa H; Traber LD; Traber DL
    Burns; 2012 Dec; 38(8):1210-5. PubMed ID: 22995423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Another "string to the bow" of PJ34, a potent poly(ADP-Ribose)polymerase inhibitor: an antiplatelet effect through P2Y12 antagonism?
    Lechaftois M; Dreano E; Palmier B; Margaill I; Marchand-Leroux C; Bachelot-Loza C; Lerouet D
    PLoS One; 2014; 9(10):e110776. PubMed ID: 25329809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The small fibrinopeptide Bβ15-42 as renoprotective agent preserving the endothelial and vascular integrity in early ischemia reperfusion injury in the mouse kidney.
    Urbschat A; Zacharowski K; Obermüller N; Rupprecht K; Penzkofer D; Jennewein C; Tran N; Scheller B; Dimmeler S; Paulus P
    PLoS One; 2014; 9(1):e84432. PubMed ID: 24392138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.
    Szabó G; Buhmann V; Andrási T; Stumpf N; Bährle S; Kékesi V; Hagl S; Szabó C; Juhász-Nagy A
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):651-8. PubMed ID: 14502135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
    Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z
    J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.